{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:06:39Z","timestamp":1784289999372,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.numecd.2026.104872","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:20:54Z","timestamp":1784204454000},"page":"104872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of patients with cardiovascular disease and overweight\/obesity: expert opinion on semaglutide use"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-0579","authenticated-orcid":false,"given":"Claudio","family":"Bilato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fucili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sbraccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104872_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the global burden of disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104872_bib2","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"45","author":"Koskinas","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104872_bib3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib4","unstructured":"Rapporto Osservasalute 2023 | osservatorio sulla salute n.d. https:\/\/osservatoriosullasalute.it\/osservasalute\/rapporto-osservasalute-2023 (accessed November 19, 2025)."},{"key":"10.1016\/j.numecd.2026.104872_bib5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104872_bib6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104872_bib7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104872_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104872_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000497124","article-title":"The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications","volume":"12","author":"Fr\u00fchbeck","year":"2019","journal-title":"Obes Facts"},{"key":"10.1016\/j.numecd.2026.104872_bib10","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2026.104872_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2026.104872_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy Obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib13","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104872_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1136340","article-title":"Obesity and cardiovascular disease: an executive document on pathophysiological and clinical links promoted by the Italian society of cardiovascular prevention (SIPREC)","volume":"10","author":"Volpe","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2026.104872_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14797\/mdcvj.1528","article-title":"Obesity and atherosclerotic cardiovascular disease: a review of social and biobehavioral pathways","volume":"21","author":"Shahid","year":"2025","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.numecd.2026.104872_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.numecd.2026.104872_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1089\/ten.tea.2014.0280","article-title":"Chondrogenic regeneration using bone marrow clots and a porous polycaprolactone-hydroxyapatite scaffold by three-dimensional printing","volume":"21","author":"Yao","year":"2015","journal-title":"Tissue Engineering - Part A"},{"key":"10.1016\/j.numecd.2026.104872_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/HJR.0b013e3282f48348","article-title":"Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index","volume":"15","author":"Sierra-Johnson","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.numecd.2026.104872_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104872_bib21","article-title":"Effects of weight loss interventions for adults who are Obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis","volume":"359","author":"Ma","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2026.104872_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104872_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.amjcard.2008.05.040","article-title":"Cardiovascular risk after bariatric surgery for obesity","volume":"102","author":"Batsis","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the look AHEAD randomised clinical trial","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2026.104872_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104872_bib26","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104872_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/oby.23621","article-title":"Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics","volume":"31","author":"Lingvay","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.numecd.2026.104872_bib28","series-title":"A secondary analysis of the SELECT trial","article-title":"Early clinical benefit of semaglutide in adults with overweight or obesity and cardiovascular disease","author":"Plutsky","year":"2023"},{"key":"10.1016\/j.numecd.2026.104872_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.2792","article-title":"Exploratory mediation analysis of the effect of semaglutide on cardiovascular outcomes in people with overweight or obesity in the SELECT randomised trial","volume":"45","author":"Colhoun","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104872_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104872_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE\u2212\/\u2212 and LDLr\u2212\/\u2212 mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC, Basic Transl Sci"},{"key":"10.1016\/j.numecd.2026.104872_bib32","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104872_bib33","first-page":"1","article-title":"Development of the european association for the study of obesity (EASO) grade-based framework on the pharmacological treatment of obesity: design and methodological aspects","author":"McGowan","year":"2025","journal-title":"Obes Facts"},{"key":"10.1016\/j.numecd.2026.104872_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2026.101521","article-title":"Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: the SCORE \u2013 primary prevention study","author":"Smolderen","year":"2026","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132601","article-title":"Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: the EYESHOT-2 registry","volume":"418","author":"De Luca","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133290","article-title":"LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry","volume":"433","author":"Colivicchi","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2026.104872_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.numecd.2026.104872_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000471488","article-title":"The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function","volume":"10","author":"Goossens","year":"2017","journal-title":"Obes Facts"},{"key":"10.1016\/j.numecd.2026.104872_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10198-021-01358-1","article-title":"The economic burden of obesity in Italy: a cost-of-illness study","volume":"23","author":"d'Errico","year":"2022","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.numecd.2026.104872_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40261-024-01365-z","article-title":"The economic burden of atherosclerotic cardiovascular disease in Italy","volume":"44","author":"Mennini","year":"2024","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.numecd.2026.104872_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40519-025-01791-8","article-title":"The burden of obesity in primary care in Italy: italian real-world overweight\/obesity study (ITROS)","volume":"30","author":"Buscemi","year":"2025","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.numecd.2026.104872_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-789X.2009.00579.x","article-title":"Obesity and overweight in Canada: an updated cost\u2010of\u2010illness study","volume":"11","author":"Anis","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.numecd.2026.104872_bib43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1177\/2047487319834770","article-title":"Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326003340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326003340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:37:21Z","timestamp":1784288241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326003340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S0939475326003340"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104872","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of patients with cardiovascular disease and overweight\/obesity: expert opinion on semaglutide use","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104872"}}